טוען...
Human anti-α3(IV)NC1 antibody drug conjugates target glomeruli to resolve nephritis
Current therapies to limit kidney disease progression lack specificity and often have systemic toxicity. To approach this problem, we postulated that a human monoclonal antibody (F1.1), directed against the noncollagenous-1 domain (NC1) of α3(IV) collagen that localizes in glomeruli, could serve as...
שמור ב:
| הוצא לאור ב: | Am J Physiol Renal Physiol |
|---|---|
| Main Authors: | , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
American Physiological Society
2015
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4609920/ https://ncbi.nlm.nih.gov/pubmed/26290372 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1152/ajprenal.00289.2015 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|